Skip to Content
Søg Menu
December 2022

Følg med når vi dækker ASH 2022 | American Society of Hematology Meeting & Exposition

MEDtalk’s fra ASH 2021

Promising Preliminary Efficacy in Patients with Relapsed/Refractory Multiple Myeloma

  • / Paul G. Richardson

Nyheder fra ASH 2021

Andrew H. Wei

Maintenance therapy: Oral azacitidine in patients with AML improves long-term overall survival

/ Andrew Wei
ASH21AML Play the Video
Alexander Fosså

CAR-T-terapi til behandling av storcellet B-cellelymfom

/ Alexander Fosså
ASH21Lymfom Play the Video
Bjørn Tore Gjertsen

Relapse vaccine is a promising treatment for patients with AML

/ Bjørn Tore Gjertsen
ASH21AML Play the Video
Hent flere

Nyt om CLL

Matthew S. Davids

ReVenG: Retreatment with venetoclax plus obinutuzumab in patients with relapsed CLL

/ Matthew S. Davids
ASH21CLL Play the Video
Paolo Ghia

How can we use Minimal Residual Disease in the treatment of CLL?

/ Paolo Ghia
ASH21CLL Play the Video
Talha Munir

MRD analysis in 1L Treatment of CLL in Elderly or Unfit patients

/ Talha Munir
ASH21CLL Play the Video
Hent flere

Nyt om Lymfomer

Manali Kamdar

CAR T Cell Therapy – a new standard of care for 2L treatment of R/R in Large B-cell Lymphoma

/ Manali Kamdar
ASH21Lymfom Play the Video
Frederick L. Locke

Real-world outcomes of axi-cel treatment of large B-cell lymphoma

/ Frederick L. Locke
ASH21Lymfom Play the Video
Judit Mészáros Jørgensen

ASH 2021: Flere opsigtsvækknede resultater for behandling af lymfomer

/ Judit Mészáros Jørgensen
ASH21Lymfom Play the Video
Hent flere

Nyt om Myelomatose

Evangelos Terpos

Safe to use Belantamab Mafodotin for transplant-ineligible patients with newly diagnosed multiple myeloma

/ Evangelos Terpos
ASH21Myelomatose Play the Video
Fredrik Schjesvold

The use of FDG PET/CT positivity as an indication for consolidation in myeloma patients after ASCT

/ Fredrik Schjesvold
ASH21Myelomatose Play the Video
Torben Plesner

Nye behandlinger med antistoffer til patienter med myelomatose patienter

/ Torben Plesner
ASH21Myelomatose Play the Video
Hent flere

Nyt om AML

Philipp Sergeev

Combination treatment of AML with spleen tyrosine kinase

/ Philipp Sergeev
ASH21AML Play the Video
Hugues-Etienne Chatel-Soulet

Does EVI1 Proto-oncogene Play a Role in the Initiation of MLL-AF9 AML?

/ Hugues-Etienne Chatel-Soulet
ASH21AML Play the Video

Post ASH: Lovende resultater for venetoclax ved behandling af AML

/ Michael Tøstesen
AMLASH20 Play the Video
Hent flere

Abstracts fra ASH 2021

The ASH Annual Meeting provides several resources on COVID-19 in hematology

/ Hæmatologi / BestPractice Nordic

Long-term remission found with combination therapy for young patients with CLL

/ Hæmatologi / BestPractice Nordic

Isatuximab + RVd bedrer MRD negativitet og prognose ved myelomatose

/ Onkologi / BestPractice Nordic

New prophylactic therapy for patients with hemophilia A and B

/ Hæmatologi / BestPractice Nordic

Polatuzumab vedotin with R-CHP for patients with diffuse large B-Cell lymphoma

/ Hæmatologi / BestPractice Nordic
Se oversigt

Gå ikke glip af det nyeste fra Hæmatologi

Skriv dig på og få nye artikler, MEDtalks og magasiner i din indbakke

Send mig seneste nyt fra hæmatologi

Nyheder fra ASH 2020

ASH2020: Outcome efter CHOP-lignende behandling ved nodal perifer T-celle lymfom

/ Ahmed Ludvigsen Al-Mashhadi
LymfomT-cellerASH20 Play the Video

ASH2020: Ny fremtidig behandlingsmulighed for myelomatose

/ Agoston Gyula Szabo
MyelomatoseASH20 Play the Video

ASH2020: Promising efficacy for “First-in-Class” immunoconjugate targeting B-cell maturation antigen

/ Agoston Gyula Szabo
MyelomatoseASH20 Play the Video
Hent flere

Back to top